Low beta-arrestin expression correlates with the responsiveness to long-term somatostatin analog treatment in acromegaly

Author(s):
Gatto, F.; Biermasz, N.R. (0000-0001-5817-3594); Feelders, R.A.; Kros, J.M.; Dogan, F.; Lely, A.J. van der; Neggers, S.J.C.M.M.; Lamberts, S.W.J.; Pereira, A.M.; Ferone, D.; Hofland, L.J.
Published
2016
Publication type
Article / Letter to editor

Abstract

Conclusions: Low beta-arrestin expression and high SSTR2/beta-arrestin ratio correlate with the responsiveness to long-term treatment with SSAs in patients with acromegaly.

Date issued
2016-05-01
Language
English
Publisher
BIOSCIENTIFICA LTD
Is part of
European Journal of Endocrinology (2016), Vol. 174, no. 5, p. 651-662
hdl
1887/99408
doi
10.1530/EJE-15-0391